C2N Diagnostics, LLC ("C2N"), a specialty diagnostics company with a vision to bring Clarity Through Innovation (R), highlighted the first use of its eMTBR-tau243 plasma assay in a Phase 3 dataset ...

Early PrimeC treatment slowed functional decline and reduced the risk of death or ALS complications for ALS patients in a ...

Discover the impact of digital pathology on drug discovery and biomarker research this International Women’s Day with Dr ...

The nonsteroidal mineralocorticoid receptor antagonist finerenone has been reported to improve kidney and cardiovascular outcomes in persons with type 2 diabetes and chronic kidney disease (CKD).

GIP obesity drug enters Phase 3 with strong cash runway, but rising competition and trial risk. Click for this VKTX update.

Introduction Climate-sensitive mortality in rapidly urbanising tropical Africa is poorly characterised, and how pandemics disrupt established seasonal patterns remains underexplored. We analysed ...

Life Sciences / Bio: ROCS X is an AI-enabled virtual screening solution that enables scientists to conduct 3D searches of over 200 trillion drug-like molecules. Target X is a physics-based AI solution ...

More than 80% of patients implanted with a transvenous phrenic nerve stimulation device for central sleep apnea had at least ...

EMP-01 met its primary objective on safety and tolerability, demonstrating a generally favorable and manageable safety and tolerability profileEMP-01 demonstrated a clinically meaningful placebo-adjus ...

On track to complete enrollment for the Phase 3 PROACT 1 accelerated approval analysis of rilparencel in mid-2026; anticipate ...

The data engineer started as a casual reader of the Jeffrey Epstein files. Then he became obsessed, and built the most ...